Cytel

Our team had an amazing time at PHUSE Connect US, with a lot of interesting conversations and presentations! We hope to see you all again next year! Rest assured, our Cytelephants will be present again as well ?? Corey Dunham Adriano M. Jonah Chates Trevano Dean Jasperlynn Kao Cralen Davis raviteja nannapaneni Manish Deole #PHUSE

We're excited to announce that we will be attending COG Nordics on April 1 & 2 in beautiful Malm?! Meet our colleagues Anna Nilsson and Russell Brown at booth 9 while you are there and discover how, through our pioneering data analytics, we simplify the journey from conception to commercialization and increase the probability of success for your trials! Book your meeting here: https://hubs.ly/Q03cFT0k0 #COGNordics #COG #ClinicalTrials

Are we meeting you at CMO Summit 360° next month? Cytel is excited to be joining other thought leaders on stage for various presentations. Be sure to catch Natasha Mühlemann and Yannis Jemiai during their panel and presentation! Also drop by booth 25 and speak with our experts on how we unlock the power of data to empower life science leaders to realize the full potential of their therapies. Book your meeting here: https://hubs.ly/Q03cwSv40 #CMO #CMOSummit

It can be challenging for sponsors to keep up with the evolving landscape of #Clinical #Data Standards. Angelo Tinazzi shares an overview of new standards, industry templates and initiatives, and #regulatory guidance. Read the post: https://hubs.ly/Q03ch-Q30 #CDISC #FDA #PHUSE

Recent advances in AI have significantly contributed towards the transformation of the life sciences Industry. While these changes will ultimately benefit our industry in the long run, we are not yet fully prepared for them. The adoption of generative AI systems, designed for human-like interactivity, raises questions that we are not just unprepared to answer but may not have even considered yet. For this interactive, live discussion, Walter Boyle, Cytel’s Vice President DMC Biostatistics, will be joined by an expert on data and AI ethics, Allie DeLonay, Senior Data Scientist at SAS’s Data Ethics Practice (DEP). Walter and Allie will discuss key topics around the ethical use of AI, both broadly and within the context of clinical development. The discussion will conclude with an open forum for attendees to share their thoughts and ask questions. Register here: https://hubs.ly/Q03cgyz00 #AI #Ethics #ClinicalDevelopment #ClinicalTrials

The Cytel team is ready to go for PHUSE Connect US! Make sure to stop by booth 27 or our various poster presentations and discover how we help empower life science leaders to realize the full potential of their therapies! Book your meeting here: https://hubs.ly/Q03c4RmT0 Corey Dunham Adriano M. Jonah Chates Elnaz Ghadimi Cralen Davis raviteja nannapaneni Trevano Dean Jasperlynn Kao Manish Deole Veena P. Rahul Panchal

Innovation in rare disease treatments is not just a scientific challenge but a moral imperative. With over 7,000 rare diseases affecting approximately 300 million people globally, the collective burden of these conditions is profound, yet solutions remain elusive for many. In our most recent eBook, we explore: ??the unique challenges of developing treatments for rare diseases ??innovative strategies in clinical trial methodologies ??the evolving regulatory landscape ??the critical importance of collaboration and adaptive thinking in addressing these unmet medical needs. Download your copy here: https://hubs.ly/Q03c1-KC0 #RareDiseases

#AI tools are evolving faster than ever, and as this #technology becomes more accessible and affordable, the drive for adoption will only grow. Walter Boyle discusses challenges and the need for open dialogue about the path forward for our industry. Read the post: https://hubs.ly/Q03bF_NK0 On March 25, Walter will be joined by Allie DeLonay from the #Data Ethics Practice at the #SAS Institute for a live discussion on the ethical use of AI. Click above to learn more and to register! #biotech #pharma #artificialintelligence #clinicaltrials #clinicaldevelopment

As clinical trials become more complex, data sources multiply, and real-world evidence (RWE) gains prominence, the statistician's role is evolving into that of clinical data scientists—hybrid professionals who combine technical expertise with strategic leadership to drive advancements in drug development. In collaboration with Alexander Schacht (The Effective Statistician Podcast), Cytel is doing a series of talks on various topics ranging from the future role of the statistician to the state of AI in our sector. For this first installment, join Alexander Schacht (The Effective Statistician Podcast), Yannis Yemiai, Benjamin Piske and Flaminia Chiesa for insights on how statisticians are leading innovation in today’s rapidly evolving clinical landscape. Register here: https://hubs.ly/Q03bGW6y0

Are you joining our experts this weekend at PHUSE Connect US? Make sure to meet up with our experts during their various speaker slots across this great four day event! If you can't make the speaker slots, drop by booth 27 and discover how we empower life science leaders to realize the full potential of their therapies! Book a meeting with our team: https://hubs.ly/Q03btkS50 #PHUSEUS